Users Coming Off Anti-Obesity Medications Gain Back Pounds Far More Rapidly Than Those on Conventional Diets

New research suggests that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who stop traditional diet and exercise plans.

Findings released in a prominent medical journal shows that while overweight people often shed substantial amounts of their body weight while on the medication, the mass comes back at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying such drugs need to be aware of the potential of fast weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of regain suggests a reversion to original mass within about a year and a half.

Comparing Approaches

The research, which reviewed 37 of studies involving over 9,000 of participants, compared the effects of GLP-1 agonists with older methods.

Researchers emphasize that individuals who lose weight through dieting typically see a more gradual creep back—approximately 100 grams monthly—post-intervention.

Explaining the Fast Regain

Experts believe the way of the drugs is key to understanding the heightened rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication leads to appetite is unsuppressed, making overeating much more probable."

An Ongoing Issue?

Health authorities advise the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals say that, due to the high risk of relapse, the therapy is often long-term.

This perspective is supported by pharmaceutical companies, who state that the findings "underscore the persistent nature of excess weight," similar to managing diseases like hypertension.

User Accounts

Individuals who have stopped the medication describe a powerful resurgence of appetite.

"I experienced a switch activating and I was suddenly ravenous," recalled a patient.

The struggle is exacerbated if users have not developed lasting lifestyle or habit changes during treatment.

Significant Use

Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand being substantial.

• Use is higher among females than males.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

In conclusion, clinicians caution that while these medications are powerful tools for shedding pounds, they are not a standalone fix and lasting health benefits likely depends on ongoing behavioural support.